These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 17091452)
1. [Gene expression of metalloproteinase 11, claudin 1 and selected adhesion related genes in papillary thyroid cancer]. Hucz J; Kowalska M; Jarzab M; Wiench M Endokrynol Pol; 2006; 57 Suppl A():18-25. PubMed ID: 17091452 [TBL] [Abstract][Full Text] [Related]
2. [Expression of selected genes involved in transport of ions in papillary thyroid carcinoma]. Gałeza-Kulik M; Zebracka J; Szpak-Ulczok S; Czarniecka AK; Kukulska A; Gubała E; Stojcev Z; Wiench M Endokrynol Pol; 2006; 57 Suppl A():26-31. PubMed ID: 17091453 [TBL] [Abstract][Full Text] [Related]
3. [Expression of DPP4 gene in papillary thyroid carcinoma]. Ozóg J; Jarzab M; Pawlaczek A; Oczko-Wojciechowska M; Włoch J; Roskosz J; Gubała E Endokrynol Pol; 2006; 57 Suppl A():12-7. PubMed ID: 17091451 [TBL] [Abstract][Full Text] [Related]
4. Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications. Jarzab B; Wiench M; Fujarewicz K; Simek K; Jarzab M; Oczko-Wojciechowska M; Wloch J; Czarniecka A; Chmielik E; Lange D; Pawlaczek A; Szpak S; Gubala E; Swierniak A Cancer Res; 2005 Feb; 65(4):1587-97. PubMed ID: 15735049 [TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study. Wasenius VM; Hemmer S; Kettunen E; Knuutila S; Franssila K; Joensuu H Clin Cancer Res; 2003 Jan; 9(1):68-75. PubMed ID: 12538453 [TBL] [Abstract][Full Text] [Related]
6. Expression of the membrane mucins MUC4 and MUC15, potential markers of malignancy and prognosis, in papillary thyroid carcinoma. Nam KH; Noh TW; Chung SH; Lee SH; Lee MK; Hong SW; Chung WY; Lee EJ; Park CS Thyroid; 2011 Jul; 21(7):745-50. PubMed ID: 21615302 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance. Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646 [TBL] [Abstract][Full Text] [Related]
9. Is the PIK3CA gene expression level in FNAB washouts equivalent to that in postoperative tissue specimens of papillary thyroid carcinoma? Wojciechowska-Durczynska K; Krawczyk-Rusiecka K; Cyniak-Magierska A; Zygmunt A; Dedecjus M; Lewinski A Neuro Endocrinol Lett; 2011; 32(1):59-63. PubMed ID: 21407159 [TBL] [Abstract][Full Text] [Related]
10. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features]. Jiang XL; Zhang H; Chen YL; Peng L Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755 [No Abstract] [Full Text] [Related]
12. [Analysis of expression of LGALS3BP gene in thyroid tissues and peripheral blood lymphocytes in patients with papillary thyroid cancer]. Kaliszewski K; Łukieńczuk T; Dobosz T; Rzeszutko M; Sadakierska-Chudy A Endokrynol Pol; 2006; 57 Suppl A():38-44. PubMed ID: 17091455 [TBL] [Abstract][Full Text] [Related]
13. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma. Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154 [TBL] [Abstract][Full Text] [Related]
14. High Diagnostic Accuracy Based on CLDN10, HMGA2, and LAMB3 Transcripts in Papillary Thyroid Carcinoma. Barros-Filho MC; Marchi FA; Pinto CA; Rogatto SR; Kowalski LP J Clin Endocrinol Metab; 2015 Jun; 100(6):E890-9. PubMed ID: 25867809 [TBL] [Abstract][Full Text] [Related]
15. The Value of HBME-1 and Claudin-1 Expression Profile in the Distinction of BRAF-Like and RAS-Like Phenotypes in Papillary Thyroid Carcinoma. Gucer H; Bagci P; Bedir R; Sehitoglu I; Mete O Endocr Pathol; 2016 Sep; 27(3):224-32. PubMed ID: 27153840 [TBL] [Abstract][Full Text] [Related]
16. The Landscape of Circular RNA Expression Profiles in Papillary Thyroid Carcinoma Based on RNA Sequencing. Lan X; Xu J; Chen C; Zheng C; Wang J; Cao J; Zhu X; Ge M Cell Physiol Biochem; 2018; 47(3):1122-1132. PubMed ID: 29847813 [TBL] [Abstract][Full Text] [Related]
17. TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma. Hawthorn L; Stein L; Varma R; Wiseman S; Loree T; Tan D Head Neck; 2004 Dec; 26(12):1069-83. PubMed ID: 15515157 [TBL] [Abstract][Full Text] [Related]
18. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer. Zhao H; Li H Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265 [TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinase-2 and its tissue inhibitor-2 in fetal and neoplastic thyroid tissue and their significance as diagnostic and prognostic markers in papillary carcinoma. Marečko I; Cvejić D; Tatić S; Dragutinović V; Paunović I; Savin S Cancer Biomark; 2011-2012; 11(1):49-58. PubMed ID: 22820140 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of estrogen receptor-α in human papillary thyroid carcinomas studied by laser- capture microdissection and molecular biology. Di Vito M; De Santis E; Perrone GA; Mari E; Giordano MC; De Antoni E; Coppola L; Fadda G; Tafani M; Carpi A; Russo MA Cancer Sci; 2011 Oct; 102(10):1921-7. PubMed ID: 21707866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]